"Emerging Fusion Protein Technologies Drive Innovation in Targeted Therapies Across Autoimmune, Cancer, Metabolic, and Cardiovascular Diseases" Boston, Dec. 11, 2025 (GLOBE NEWSWIRE) -- According to ...
General Fusion Inc. (“General Fusion” or the “Company”), a leader in the global race to make commercial fusion energy a reality, today announced its participation in several prominent global ...
Global energy demand is projected to surge 80% by 2050. To meet this challenge, fusion—offering reliable, affordable, and abundant power—represents the most significant market opportunity of the 21st ...
This collaboration will focus on establishing reliable supply chains for SHINE’s portfolio of products and services, including critical medical isotopes like lutetium-177 and molybdenum-99, neutron ...
Pioneering Startup Pivots from Fusion Propulsion to Accelerate Commercial Fusion with Compact NBI Technology SAN FRANCISCO, Oct. 22, 2025 /PRNewswire/ -- Eos Atomics, formerly known as AeroFuse, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results